Quarterly Pathology / Immunohistochemistry Conference

PhenoPath Laboratories hosts quarterly evening pathology/immunohistochemistry conferences at our facility in the Fremont neighborhood of Seattle. These provide a venue where Seattle-area pathologists can meet regularly on an informal basis, share interesting cases, and learn from each other. The format of the conference is a Social Hour beginning at 6:30 pm, followed by a lecture by an invited speaker at 7:30 pm and concluding with interesting case presentations. See our Contact Us page for directions to PhenoPath.

Quarterly Conference Speakers 2008

• February 7, 2008
  Lawrence Weiss, MD, Chairman, Division of Pathology, City of Hope, Duarte, CA
  What’s New in WHO in Lymphomas
  
  
• May 8, 2008
  Steven Shak, MD, Chief Medical Officer, Genomic Health, Inc., Redwood, CA
  Making Personalized Medicine a Reality: Lessons from Trastuzumab and Oncotype DX
  
  
• August 7, 2008
  Jeffrey L. Myers, MD, A. James French Professor and Director. Division of Anatomic Pathology, University of Michigan, Ann Arbor, MI
  
  
• November 6, 2008
  John R. Goldblum, MD, Chairman, Dept. of Anatomic Pathology and Professor of Pathology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH
  Controversies in the Diagnosis of Barrett’s Esophagus and Barrett’s-Related Dysplasia
  
  

Quarterly Conference Speakers 2007

• February 26, 2007
  Prof. David Y. Mason, Haematology Dept, John Radcliffe Hospital, Oxford, UK
  New Immunohistological Markers of Human Haematopoietic Tissue
  
  
• May 10, 2007
  Jeannette Guarner, MD, Infectious Disease Pathology Activity, Centers for Disease Control and Prevention, Atlanta, Georgia
  Use of Immunohistochemistry in Detection of Emerging and Reemerging Infectious Diseases
  
  
• August 2, 2007
  David L. Rimm, MD, PhD, Professor of Pathology, Director, YCC Tissue Microarray Facility, Cytopathology Fellowship Program Director, Department of Pathology, Yale University School of Medicine, New Haven, CT
  Biomarker Discovery by Quantitative and Multiplexed Anaylsis of Tissue Microarrays
  
  
• November 29, 2007
  John Walsh, MD, Dermatopathology Northwest, Bellevue, WA
  A Potpourri of Interesting Dermatologic Cases
  
  

Quarterly Conference Speakers 2006

• March 2, 2006
  Todd S. Barry, M.D., Ph.D., and Steven J. Kussick, M.D., Ph.D., PhenoPath Laboratories; Seattle, WA
  Hematopathology in the Post-WHO World: What the Practicing Pathologist Needs to Know
  
  
• May 11, 2006 (Note: Date has been changed from May 18)
  Torsten Nielsen, M.D., Ph.D., FRCPC, Assistant Professor in Pathology, University of British Columbia, Vancouver, BC Canada
  Translating Expression Profiles into Clinical Care
  
  
• August 10, 2006
  Linda Ferrell, MD, Vice-Chair Clinical Affairs Director, Surgical Pathology Director, University of California San Francisco
  Update on Fatty Liver Disease
  
  
• November 2, 2006
  David G. Bostwick, MD, MBA, CEO & Medical Director, Bostwick Laboratories
  Diagnostic Problems in Prostatic Adenocarcinoma
  • Improved Filter Method for Urine Sediment Detection of Urothelial Carcinoma by FISH
  • Pathology of Prostate Cancer 2006

Quarterly Conference Speakers 2005

• February 17, 2005
  Dr. Mary Bronner, The Cleveland Clinic; Cleveland, OH
  Neoplastic Progression in Ulcerative Colitis: From Chromosomes to the Clinic
  
  
• May 12, 2005
  Dr. Phillip Clement, University of British Columbia; Vancouver, BC Canada
  The Role of Immunohistochemistry in the Diagnosis of Uterine Mesenchymal Tumors
  
  
• August 4, 2005
  Dr. Bruce Wenig, Beth Israel Medical Center; New York, NY
  Thyroid Papillary Carcinoma: Usual Type and Subtypes
  
  
• November 17, 2005 (Note: Date has been changed from November 10)
  Dr. Craig Allred, Baylor College of Medicine; Houston, TX
  Assessing ER and PR in Breast Cancer by IHC: Standardization and Validation

Quarterly Conference Speakers 2004

• February 24th, 2004
  Dr. Hadi Yaziji, PhenoPath Laboratories; Seattle, WA
  Lessons Learned from FISH Testing in the Pathology Laboratory
  
  
• May 6th, 2004
  Dr. Stuart Schnitt, Beth Israel Deaconess Medical Center; Boston, MA
  Uses and Limitations of IHC in Breast Pathology
  
  
• August 5th, 2004
  Dr. Andrew Folpe, Emory University; Atlanta, GA
  Immunohistochemistry in the Evaluation of Soft Tissue Neoplasms - an Update
  
  
• November 18th, 2004
  Dr. Randy Gascoyne, British Columbia Cancer Agency; Vancouver, BC Canada
  Follicular Lymphoma and the Immune Microenvironment

Quarterly Conference Speakers 2003

• February 11th, 2003
  Dr. Hector Battifora, Pathology Consultation Service; Arcadia, CA
  Novel Markers and Applications
  
  
• May 6th, 2003
  Dr. Rich Cartun, Hartford Hospital; Hartford, CT
  Identification of Infectious Organisms by Immunohistochemical Methods
  
  
• August 5th, 2003
  Dr. Neal Goldstein, William Beaumont Hospital; Royal Oak, MI
  Expression of Cytokeratins 7 and 20 in Adenocarcinomas
  
  
• November 5th, 2003
  Dr. Clive Taylor, University of S. California Medical School; Los Angeles, CA
  Vision 2020-the Past, Present and Future of Surgical Pathology